- Home
- WFF vs TARA Comparison
WFF vs TARA Comparison
Compare WFF & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFF
- TARA
- Stock Information
- Founded
- WFF 1984
- TARA N/A
- Country
- WFF Malaysia
- TARA United States
- Employees
- WFF N/A
- TARA N/A
- Industry
- WFF Miscellaneous manufacturing industries
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WFF Consumer Discretionary
- TARA Health Care
- Exchange
- WFF Nasdaq
- TARA Nasdaq
- Market Cap
- WFF 155.9M
- TARA 126.5M
- IPO Year
- WFF 2025
- TARA N/A
- Fundamental
- Price
- WFF $2.45
- TARA $2.86
- Analyst Decision
- WFF
- TARA Strong Buy
- Analyst Count
- WFF 0
- TARA 7
- Target Price
- WFF N/A
- TARA $20.67
- AVG Volume (30 Days)
- WFF 2.2M
- TARA 452.7K
- Earning Date
- WFF 01-01-0001
- TARA 08-05-2025
- Dividend Yield
- WFF N/A
- TARA N/A
- EPS Growth
- WFF N/A
- TARA N/A
- EPS
- WFF 0.00
- TARA N/A
- Revenue
- WFF $4,572,290.00
- TARA N/A
- Revenue This Year
- WFF N/A
- TARA N/A
- Revenue Next Year
- WFF N/A
- TARA N/A
- P/E Ratio
- WFF $900.59
- TARA N/A
- Revenue Growth
- WFF N/A
- TARA N/A
- 52 Week Low
- WFF $1.91
- TARA $1.60
- 52 Week High
- WFF $29.26
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- WFF N/A
- TARA 43.02
- Support Level
- WFF N/A
- TARA $3.12
- Resistance Level
- WFF N/A
- TARA $3.10
- Average True Range (ATR)
- WFF 0.00
- TARA 0.19
- MACD
- WFF 0.00
- TARA -0.01
- Stochastic Oscillator
- WFF 0.00
- TARA 17.19
About WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).